LEDERMAN SETH (Chief Executive Officer) purchased 472.3% of their position (20K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market
Open‑market purchase worth $34.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/1/2022ACC: 0001387131-22-007441
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+20K
Net shares
Net buyer
$34.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Indirect
Shares
+20K
Price / share
$1.71
Trade value
$34.20K
% of position
472.3%
6/29/2022
4.24K→24.23K
Total
Net shares
+20K
Net value
$34.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Indirect | 6/29/2022 | P · Purchase | +20K | $1.71 | $34.20K | 472.3% | 4.24K | 24.23K |
| Total | +20K | $34.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)7
Common Stock, $0.001 par value
DirectShares owned3.50K
Common Stock, $0.001 par value
IndirectShares owned2.00
Common Stock, $0.001 par value
IndirectShares owned1.00
Common Stock, $0.001 par value
IndirectShares owned1.00
Common Stock, $0.001 par value
IndirectShares owned7.00
Common Stock, $0.001 par value
IndirectShares owned1.00
Common Stock, $0.001 par value
IndirectShares owned2.00
Total
3.50K direct·14.00 indirect3.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 3.50K | Direct |
| Common Stock, $0.001 par value | 2.00 | Indirect |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Common Stock, $0.001 par value | 7.00 | Indirect |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Common Stock, $0.001 par value | 2.00 | Indirect |
| Total | 3.52K | 3.50K direct·14.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported